CervoMed (CRVO)

• Market cap: $118M
• 1 day: 23.62%
• 5 days: 102.12%
• 1 month: 526.75%
• 3 months: 546.61%
• 6 months: -8.40%
• Year to date: 540.81%
• 1 year: -36.43%
• 5 years: -5.99%
• 10 years: -99.55%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

30% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 10

6% less funds holding

Funds holding: 49 [Q3] → 46 (-3) [Q4]

19% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 16

24.53% less ownership

Funds ownership: 42.54% [Q3] → 18.01% (-24.53%) [Q4]

93% less capital invested

Capital invested by funds: $51.2M [Q3] → $3.46M (-$47.8M) [Q4]

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $10 30% downside
• Avg. target: $16 12% upside
• High target: $21 47% upside

5 analyst ratings

• positive: 5 100%
• neutral: 0 0%
• negative: 0 0%

Roth MKM Boobalan Pachaiyappan 40% 1-year accuracy 4 / 10 met price target	40% upside $20	Buy Maintained	18 Mar 2025
Canaccord Genuity Sumant Kulkarni 24% 1-year accuracy 8 / 33 met price target	47% upside $21	Buy Maintained	18 Mar 2025
Chardan Capital Daniil Gataulin 28% 1-year accuracy 12 / 43 met price target	2% downside $14	Buy Maintained	18 Mar 2025
D. Boral Capital Jason Kolbert 31% 1-year accuracy 92 / 297 met price target	30% downside $10	Buy Maintained	17 Mar 2025
Jones Trading Soumit Roy 25% 1-year accuracy 4 / 16 met price target	5% upside $15	Buy Upgraded	13 Mar 2025